Are COVID Vaccine Makers Overly Optimistic About Their Capacity?
Pfizer (NYSE: PFE) originally expected to produce close to 100 million doses of COVID-19 vaccine BNT162b2 by the end of the year. However, the big drugmaker later slashed its estimate to 50 million doses. In this Motley Fool Live video recorded on Dec. 9, 2020, Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com writer Keith Speights discuss whether other COVID vaccine makers could also be overly optimistic about their capacity.
Source Fool.com